Close
Smartlab Europe
Inizio Ignite

Nemera receives Drug Manufacturing Authorization for its Neuenburg plant, in Germany

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Predictive Analytics in Labs: Driving Smarter Decisions in Pharma

The application of statistical algorithms and machine learning techniques to historical research data is enabling scientists to anticipate experimental outcomes and identify emerging patterns with unprecedented accuracy. By moving from a retrospective view of data to a forward-looking perspective, research facilities can optimize their strategies and focus their resources on the most promising therapeutic avenues.

IoT Applications Enhancing Laboratory Operational Efficiency

The integration of internet-connected sensors and smart devices is fundamentally reshaping how research facilities monitor their environment and manage their instrumentation. By providing a constant stream of real-time data, these technological advancements allow for a more granular level of control over laboratory operations, ensuring that the delicate conditions required for high-stakes pharmaceutical research are maintained with absolute precision.

Optimizing Pharma Workflows with Integrated Lab Software Solutions

The modern laboratory environment requires a unified approach to data management and process control to remain competitive. By bridging the gap between disparate instruments and legacy databases, research facilities can eliminate operational silos and create a high-speed environment where innovation is no longer hindered by fragmented digital infrastructure.
- Advertisement -

Nemera received from the German Government Drug Administration (Government Presidium, Tübingen) the Pharmaceutical Drug Manufacturing Authorization according to §13 AMG (German Drug & Medicinal Product Law) at its Neuenburg manufacturing facility in Germany.

The certification gives the manufacturing plant the approval to handle, assemble, sterilize and store pharmaceutical drugs and medicinal products for autoinjectors.
This approval reflects Nemera’s commitment to quality in developing and manufacturing drug delivery devices.

Indeed, the authorization is an important achievement. It confirms that Nemera meets the highest standards required to ensure the manufacturing and testing of the above-mentioned drug, as well as medicinal and medical products. The pharmaceutical drug manufacturing certification is a required regulatory step, in order to allow Nemera to provide a complete set of services and additional support, for the development and manufacturing of pharmaceutical combination products and drug delivery devices to our customers

“Achieving this pharmaceutical drug manufacturing approval is highlighting our commitment to ensure the safety of our drug delivery devices for the benefit of patients. It is also the confirmation that our quality systems and processes are meeting consistently regulatory requirements and patient expectations.” commented Christian Meusinger, Quality Vice-President of Nemera.

The Neuenburg plant
The Neuenburg plant has been manufacturing high quality products since 1953.
With more than 20,000 sqm of built up area, the plant has Class 8 clean rooms and more than 400 employees, to guarantee a 7/7 and 24h/24 production.
Neunburg plant produces billions of Injection molded parts and assembled devices every year.

Neuenburg quality management key achievements are:
• Short reaction times
• Detailed and comprehensive root cause analysis
• Elimination of quality problems
• Reduction of scrap rates
• Elimination of inefficiencies

About Nemera
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Parenteral (auto-injectors, pens, safety devices & implanters), Ophthalmic (multi-dose, preservative-free eyedroppers), Nasal, buccal, auricular (pumps, valves and actuators for sprays), Inhalation (pMDIs, DPIs), Dermal and transdermal (airless & atmospheric dispensers).
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer-owned device manufacturing.

Latest stories

Related stories

Predictive Analytics in Labs: Driving Smarter Decisions in Pharma

The application of statistical algorithms and machine learning techniques to historical research data is enabling scientists to anticipate experimental outcomes and identify emerging patterns with unprecedented accuracy. By moving from a retrospective view of data to a forward-looking perspective, research facilities can optimize their strategies and focus their resources on the most promising therapeutic avenues.

IoT Applications Enhancing Laboratory Operational Efficiency

The integration of internet-connected sensors and smart devices is fundamentally reshaping how research facilities monitor their environment and manage their instrumentation. By providing a constant stream of real-time data, these technological advancements allow for a more granular level of control over laboratory operations, ensuring that the delicate conditions required for high-stakes pharmaceutical research are maintained with absolute precision.

Optimizing Pharma Workflows with Integrated Lab Software Solutions

The modern laboratory environment requires a unified approach to data management and process control to remain competitive. By bridging the gap between disparate instruments and legacy databases, research facilities can eliminate operational silos and create a high-speed environment where innovation is no longer hindered by fragmented digital infrastructure.

Advanced Robotics Driving Pharmaceutical Lab Efficiency

The implementation of high-speed robotic systems and automated handling technologies is fundamentally altering the productivity of modern research facilities. By taking over repetitive physical tasks and operating with sub-millimeter precision, these mechanical innovators are allowing scientific staff to redirect their cognitive energy toward complex analysis and the development of breakthrough therapies.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »